Form 4: Claritev Officer Reports RSU Grant, Tax Withholding
Insider Transaction Report
Claritev Corp's SVP, Chief Growth Officer, Tiffani Misencik, reported the acquisition of 26,342 restricted stock units and the disposition of shares for tax purposes and cash-settled RSUs.
Summary
- SVP, Chief Growth Officer Tiffani Misencik reported transactions on March 1, 2026, related to her holdings in Claritev Corp (CTEV).
- 1,660 Class A common shares were disposed of at a price of $13.47 per share to cover tax obligations associated with the vesting of restricted stock units granted on March 1, 2025.
- Misencik acquired 26,342 new restricted stock units (RSUs) with a grant price of $0.
- These newly granted RSUs are scheduled to vest at a rate of 25% per year on March 1, 2027, 2028, 2029, and 2030.
- 10,123 cash-settled restricted stock units (cRSUs), originally granted on March 1, 2025, were settled in cash due to 50% vesting on March 1, 2026.
- Following these reported transactions, Misencik beneficially owns 132,573 Class A common shares and 10,124 cash-settled restricted stock units.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as slightly positive due to the significant grant of new restricted stock units, which aligns executive incentives with long-term shareholder value, despite routine tax-related dispositions.
Positives
- The grant of 26,342 new restricted stock units (RSUs) indicates continued long-term incentive for the SVP, Chief Growth Officer, aligning executive interests with future company performance.
Negatives
- 1,660 Class A common shares were disposed of to cover tax liabilities, representing a reduction in direct share ownership.
- 10,123 cash-settled restricted stock units were disposed of through cash settlement, reducing derivative holdings.
Future Outlook
The newly granted restricted stock units will vest over a four-year period, with 25% vesting annually from March 1, 2027, through March 1, 2030, indicating a long-term incentive structure for the executive.
Industry Context
StockSavvy.ai notes that routine Form 4 filings, such as this one, primarily detail executive compensation and ownership changes, offering limited direct insight into broader industry trends or competitive positioning. These filings are standard for publicly traded companies to ensure transparency in insider transactions.
Stakeholder Impact
- Shareholders: Minor dilution from RSU grants over time, but also aligns executive incentives with long-term company performance.
- Employees: Reflects standard executive compensation practices for key personnel.
Next Steps
- Vesting of 25% of the 26,342 restricted stock units on March 1, 2027.
- Vesting of 25% of the 26,342 restricted stock units on March 1, 2028.
- Vesting of 25% of the 26,342 restricted stock units on March 1, 2029.
- Vesting of 25% of the 26,342 restricted stock units on March 1, 2030.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Grant date of restricted stock units and cash-settled restricted stock units that vested on March 1, 2026. |
| 03/01/2026 | Transaction date for share disposition for taxes, RSU grant, and cash settlement of cRSUs. |
| 03/01/2027 | First vesting date (25%) for the newly granted 26,342 restricted stock units. |
| 03/01/2028 | Second vesting date (25%) for the newly granted 26,342 restricted stock units. |
| 03/01/2029 | Third vesting date (25%) for the newly granted 26,342 restricted stock units. |
| 03/01/2030 | Fourth and final vesting date (25%) for the newly granted 26,342 restricted stock units. |
| 03/03/2026 | Signature date of the filing by attorney-in-fact. |
Recommendation
holdThis Form 4 details routine executive compensation transactions, including a new RSU grant and tax-related dispositions. While the RSU grant aligns executive incentives, these transactions are standard and do not provide new fundamental information to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing does not present significant new catalysts for either upward or downward price movement.
Keywords
Claritev Corp, CTEV, Tiffani Misencik, Form 4, insider transaction, restricted stock units, RSU grant, tax withholding, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.